CAR-T Cell Therapy Resource Center
News & Information for Healthcare Professionals
At the Bench-Glioblastoma: Immunotherapy for Glioblastoma Has a New and Potentially Powerful Target
April 5, 2018 (Neurology Today)
A protein associated with glioblastoma multiform (GBM) has been identified and in experiments has proven to be a promising...
This ‘genetic switch’ could help to fight cancer
April 27, 2018 (Medical News Today)
T cells, a type of white blood cell, have an innate ability to recognize, attack and kill cancer...
Immunotherapy Promising for Slowing Progression of ALS
June 4, 2018 (HealthDay News)
Positive results seen for autologous infusions of expanded regulatory T lymphocytes in three patients
MONDAY, June 4, 2018 (HealthDay News) —...
New Study Finds that Lowering Cholesterol Improves Immunotherapy
May 19, 2018 (Medical News Today)
This study was published in the Journal of Experimental Medicine. It discovered that when cholesterol levels are decreased, cancer...
Combo of Chemo & Immunotherapy Determined Feasible in Metastatic Bladder Cancer
April 11, 2018 (HealthDay News)
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
Gemcitabine and cisplatin (GC) plus ipilimumab is associated with...
CAR T-Cell Immunotherapy Named Clinical Advance of the Year by ASCO
In January, ASCO published its 13th annual report in Clinical Cancer Advances 2018, and named chimeric antigen receptor (CAR) T-cell immunotherapy as its Advance...
CAR T-Cell Therapy HCP Guide – Future Implications for CAR T-Cell Therapy
What's Next for CAR T-Cell Therapy?
Top issues for researchers and clinicians utilizing CAR T-cell therapy include:
Shortening the manufacturing time and vein-to-vein time, scaling...
The Goal of Armored CAR T Cells
Dr. Renier Brentjens, MD, PhD from the Memorial Sloan Kettering Cancer Center, discusses the goal of armored CAR T-cells. He talks about how the...
‘Cross-dressing’ cells may improve cancer treatment
January 23, 2018 (Medical News Today)
A group of researchers from Switzerland are now focused on improving ‘dendritic cell vaccines’, which are an important...
